Belén De la Hoz Caballer

Belén De la Hoz Caballer


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2015 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
Javier Martinez-BotasJavier Martinez-Botas
Javier Martinez-Botas
MRM. Rodríguez‐Álvarez
M. Rodríguez‐Álvarez
ICI. Cerecedo
I. Cerecedo
CVC. Vlaicu
C. Vlaicu
MDMª. C. Diéguez
Mª. C. Diéguez
Belén De la Hoz CaballerBelén De la Hoz Caballer
Belén De la Hoz Caballer

1 September 2009 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Open access
PDF file
Belén De la Hoz CaballerBelén De la Hoz Caballer
Belén De la Hoz Caballer
CSC. Colás Sanz
C. Colás Sanz
MRM. Rodríguez Rodríguez
M. Rodríguez Rodríguez
.F. Grupo Freedom
. Grupo Freedom
Calidad de vida en pacientes con rinitis alérgica: estudio comparativo con la hipertensión arterial en el ámbito de atención primaria

29 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
CLCarlos Fernández Lozano
Carlos Fernández Lozano
ESEmilio Solano-Solares
Emilio Solano-Solares
IEIsabel Elías-Sáenz
Isabel Elías-Sáenz
IPIsabel Pérez-Allegue
Isabel Pérez-Allegue
Montserrat Fernández-GuarinoMontserrat Fernández-Guarino
Montserrat Fernández-Guarino
Belén De la Hoz CaballerBelén De la Hoz Caballer
Belén De la Hoz Caballer
In the first wave of COVID-19, up to 20% of patients had skin lesions with variable characteristics. There is no clear evidence of the involvement of the SARS-CoV-2 virus in all the cases; some of these lesions may be secondary to drug hypersensitivity. To analyze the possible cause of the skin lesions, we performed a complete allergology study on 11 patients. One year after recovery from COVID-19, we performed a lymphocyte transformation test (LTT) and Th1/Th2 cytokine secretion assays of PBMC. We included 5 nonallergic patients treated with the same drugs without lesions. Except for one patient who had an immediate reaction to azithromycin, all patients had a positive LTT to at least one of the drugs tested (azithromycin, clavulanic acid, hydroxychloroquine, lopinavir, and ritonavir). None of the nonallergic patients had a positive LTT. We found mixed Th1/Th2 cytokine secretion (IL-4, IL-5, IL-13, and IFN-γ) in patients with skin lesions corresponding to mixed drug hypersensitivity type IVa and IVb. In all cases, we identified a candidate drug as the culprit for skin lesions during SARS-CoV-2 infection, although only three patients had a positive drug challenge. Therefore, it would be reasonable to recommend avoiding the drug in question in all cases.